Daunorubicin hydrochloride

CAS No. 23541-50-6

Daunorubicin hydrochloride ( RP 13057 Hydrochloride;Daunomycin;RP13057 Hydrochloride )

Catalog No. M13676 CAS No. 23541-50-6

Daunorubicin is potent topoisomerase II (Topo II) inhibitor, interacts with DNA by intercalation and inhibition of macromolecular biosynthesis in cancer cells.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 28 In Stock
10MG 46 In Stock
25MG 76 In Stock
50MG 110 In Stock
100MG 177 In Stock
200MG 282 In Stock
500MG 443 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Daunorubicin hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Daunorubicin is potent topoisomerase II (Topo II) inhibitor, interacts with DNA by intercalation and inhibition of macromolecular biosynthesis in cancer cells.
  • Description
    Daunorubicin is potent topoisomerase II (Topo II) inhibitor, interacts with DNA by intercalation and inhibition of macromolecular biosynthesis in cancer cells; Daunorubicin is a chemotherapy agent used to treat multiple cancer, secifically used for acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), chronic myelogenous leukemia (CML), and Kaposi's sarcoma; Daunorubicin and it's derivatives are widely used as payloads in antibody-drug conjugates (ADCs).Chemotherapeutic Agents Approved
  • Synonyms
    RP 13057 Hydrochloride;Daunomycin;RP13057 Hydrochloride
  • Pathway
    Antibody Drug Conjugates (ADC)
  • Target
    ADC Cytotoxin
  • Recptor
    DNAsynthesis
  • Research Area
    Cancer
  • Indication
    Chemotherapeutic

Chemical Information

  • CAS Number
    23541-50-6
  • Formula Weight
    563.98
  • Molecular Formula
    C27H30ClNO10
  • Purity
    >98% (HPLC)
  • Solubility
    H2O: ≥ 34 mg/mL
  • SMILES
    C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)C)O)N)O.Cl
  • Chemical Name
    5,12-Naphthacenedione, 8-acetyl-10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, hydrochloride (1:1), (8S,10S)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Latif ZA, et al. Cancer. 1980 Mar 15;45(6):1326-33.
2. Hurwitz E, et al. Int J Cancer. 1979 Oct 15;24(4):461-70.
3. Aboud-Pirak E, et al. Proc Natl Acad Sci U S A. 1989 May;86(10):3778-81.
molnova catalog
related products
  • D211

    A novel potent DNA-intercalating payload dimer (PBD dimer) payload for antibody-drug conjugates (ADCs); displays picomolar potency against AML cancer cell lines.

  • MMAD hydrochloride

    A potent tubulin inhibitor that is a toxin payload in antibody drug conjugates (ADCs).

  • Mertansine

    Mertansine (DM1) is a tubulin inhibitor; thiol-containing maytansinoid that create an antibody-drug conjugate (ADC); an ADC payload.